Each year IFCN is obliged to have a General Assembly to relate its activities over the year to member societies. It is a relatively formal affair, with ExCo members giving short summaries. We also remember members of the IFCN who died during the year. This year we lost two much respected peripheral neurophysiologists and neurologists, Austin Sumner and Peter Dyck. Then, just before the GA, the death of Professor Mark Hallett was announced. He will have been known to many readers and had an extraordinary record of publication and of service to neuroscience. We are fortunate he did so much for IFCN including being Editor-in-Chief of Clinical Neurophysiology and our President. His obituaries can be seen in that journal, on our website and in other journals too. We will not see his like again.
Read More
Clinical Neurophysiology is the official journal of IFCN and its member Societies. It has been adopted as the official journal of the Italian Society of Clinical Neurophysiology, the Czech Society of Clinical Neurophysiology, the Brazilian Society of Clinical Neurophysiology and the International Society of Intraoperative Neurophysiology.
Clinical Neurophysiology is dedicated to publishing scholarly reports on the pathophysiology underlying diseases of the peripheral and central nervous system of humans.
Clinical Neurophysiology Practice (CNP) is a new Open Access journal that focuses on clinical practice issues in clinical neurophysiology including relevant new research, case reports or clinical series, normal values and didactic reviews. It complements Clinical Neurophysiology which focuses on innovative research in the specialty. It has a role in supporting established clinical practice, and an educational role for trainees, technicians and practitioners.
It is with great sadness that we announce the recent death of Professor Mark Hallett on November 2, 2025. He was a towering figure in clinical neurophysiology during the last fifty or so years. Though active in several societies, we remember him for his commitment to clinical neurophysiology over many years, as Editor-in-Chief of Clinical Neurophysiology and President of the IFCN amongst many other roles. He was also so active at our International Congresses and in other teaching. We will not see his like again.
A full obituary will be published in Clinical Neurophysiology. To read a list of many personal memories of Mark, please click below.
For further information: Mark Hallet Memories
On behalf of Jorge Gutierrez and Hatice Tankisi, co-chairs of the Scientific Program Committee, we are delighted to invite you to submit a proposal for presentation for the scientific symposia sessions for the 34th International Congress of Clinical Neurophysiology (ICCN 2026), which will take place at the Centro de Convenciones Cartagena de Indias Convention Center in Cartagena, Colombia, September 8-12, 2026.
Deadline - February 1, 2026
Registration Fee includes access to the Symposium sessions from September 10-12, 2026, the welcome reception and ceremony,award plenary lectures, lunch, posters and closing ceremony.
The International Federation of Clinical Neurophysiology (IFCN) has 68 member societies in 65 countries.
The IFCN mission is to promote best practice in clinical neurophysiology through education and research throughout the world. And our vision is to improve healthcare worldwide by understanding the nervous system and optimizing the diagnosis and treatment of its disorders through clinical neurophysiology.
Clinical Neurophysiology is a medical specialty focused on evaluating the function and dysfunction of the nervous system, including the brain, spinal cord, peripheral nerves, and muscles, through physiological and imaging techniques that measure nervous system activity. When interpreted alongside a patient’s clinical presentation, data from these techniques can diagnose or assist in the diagnosis of neurological and psychiatric conditions, as well as quantify, monitor, and track their progression. Clinical neurophysiology also encompasses the use of physiological methods for the therapeutic management of neurological and psychiatric disorders.
